Summary of a Public FDA Workshop: Model Informed Drug Development Approaches for Immunogenicity Assessments.
Belov AA, Rodriguez Messan M, Yogurtcu ON, Schultz K, Maxfield K, Thompson L, Revell S, Warren-Henderson Y, Tegenge MA, Sauna ZE, Forshee RA.
Belov AA, et al. Among authors: maxfield k.
Clin Pharmacol Ther. 2023 Feb;113(2):221-225. doi: 10.1002/cpt.2572. Epub 2022 Mar 24.
Clin Pharmacol Ther. 2023.
PMID: 35253213
No abstract available.